Not checked for notices yet.
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal and 1 more (opens in a new tab)
Frontiers in Immunology · 2020
doi:10.3389/fimmu.2020.00508 (opens in a new tab)
Cited by papers we hold 3
- CD39/CD73/A2AR pathway and cancer immunotherapy · 2023No notice
- First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors · 2023No notice
- Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy · 2022No notice
Questions about this paper
We email you if it is retracted, withdrawn, corrected or flagged.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.